NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
28/01/2025
Voltar para busca
Dado oficial do USPTO
NEUROCENTRX
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
26
Atualização mais recente
03/04/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5, 42
Data de depósito
28/06/2023
Data de registro
28/01/2025
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
28/01/2025
Última transação
03/04/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
99
Localização do titular
GB
Examinador
KAPLAN, VALERIE ELIZABETH
Unidade examinadora
L70
Localização atual
FILE REPOSITORY (FRANCONIA)
Titulares e representantes
Titulares
Neurocentrx pharma ltd
Representantes
MICHELLE A. COOKE ARENTFOX SCHIFF LLP
Classificação técnica
Classes Nice
Classe 5Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Pharmaceutical and veterinary preparations for the treatment and promotion of mental health and wellnessfor the treatment and prevention of mental health diseases and disorderspsychiatric diseases and disordersmood disordersdepressionanxietystressfatiguesleeping disorderseating disorderspaininflammation; pharmaceutical compositions in the nature of pharmaceutical preparations for the treatment and promotion of mental health and wellnessfor the treatment and prevention of mental health diseases and disorderspsychiatric diseases and disordersmood disordersdepressionanxietystressfatiguesleeping disorderseating disorderspaininflammation; pharmaceutical preparations for the treatment and promotion of mental health and wellnessfor the treatment and prevention of mental health diseases and disorderspsychiatric diseases and disordersmood disordersdepressionanxietystressfatiguesleeping disorderseating disorderspaininflammation; herbal medicine preparations; implantable medicinesimplantable subcutaneous drug delivery devices sold filled with pharmaceutical preparations for the treatment and promotion of mental health and wellnessfor the treatment and prevention of mental health diseases and disorderspsychiatric diseases and disordersmood disordersdepressionanxietystressfatiguesleeping disorderseating disorderspaininflammation; capsules for medicinesnamely capsules sold empty for pharmaceuticals; medicines for human purposespharmaceutical preparations for the treatment and promotion of mental health and wellnessfor the treatment and prevention of mental health diseases and disorderspsychiatric diseases and disordersmood disordersdepressionanxietystressfatiguesleeping disorderseating disorderspaininflammation; pharmaceutical skin lotions; pharmaceutical creams for the treatment and promotion of mental health and wellnessfor the treatment and prevention of mental health diseases and disorderspsychiatric diseases and disordersmood disordersdepressionanxietystressfatiguesleeping disorderseating disorderspaininflammation; pharmaceutical preparations in strip form for the treatment and promotion of mental health and wellnessfor the treatment and prevention of mental health diseases and disorderspsychiatric diseases and disordersmood disordersdepressionanxietystressfatiguesleeping disorderseating disorderspaininflammation; lotions for pharmaceutical purposes for the treatment and promotion of mental health and wellnessfor the treatment and prevention of mental health diseases and disorderspsychiatric diseases and disordersmood disordersdepressionanxietystressfatiguesleeping disorderseating disorderspaininflammation
Classe 42
Research relating to medicine; research and development in the field of medicine; development of pharmaceutical preparations and medicines; research relating to medicines
Publicações
Histórico de despachos e eventos da marca no USPTO.
26 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
28/01/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/12/2024
PUBO
PUBLISHED FOR OPPOSITION
10/12/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/12/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/12/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/12/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/12/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/11/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
15/10/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
15/10/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
15/10/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/10/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
07/10/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
07/10/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
07/10/2024
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
07/10/2024
RFNT
REFUSAL PROCESSED BY IB
08/05/2024
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
17/04/2024
RFRR
REFUSAL PROCESSED BY MPU
16/04/2024
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
28/03/2024
CNRT
NON-FINAL ACTION WRITTEN
27/03/2024
DOCK
ASSIGNED TO EXAMINER
13/03/2024
MAFR
APPLICATION FILING RECEIPT MAILED
24/10/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
20/10/2023
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
19/10/2023
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace NEUROCENTRX ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.